Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part Placebo-Controlled Evaluation of the Safety and Immunogenicity of an A/Indonesia/5/05 Recombinant Hemagglutinin Influenza H5N1 Vaccine With and Without Glucopyranosyl Lipid A (GLA-SE) in Healthy Adults 18-49

NCT01147068 is registered in ClinicalTrials.gov with Protein Sciences Corporation as lead sponsor.

NCT NCT01147068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01147068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part Placebo-Controlled Evaluation of the Safety and Immunogenicity of an A/Indonesia/5/05 Recombinant Hemagglutinin Influenza H5N1 Vaccine With and Without Glucopyranosyl Lipid A (GLA-SE) in Healthy Adults 18-49
Lead sponsor
Protein Sciences Corporation
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2010
Completion date
October 31, 2011
Enrollment
392 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza